Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.

Anjuli Nayak, Niroo Gupta, S. David Miller et al.|PubMed|2004

Cited by 45